Cargando…
Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort
OBJECTIVE: This study aimed to compare cause‐specific mortality rates in patients with type 2 diabetes with and without various vascular complications. METHODS: In Japanese hospitals, we followed up 30 834 patients with a mean age of 64.4 (standard deviation [SD]: 11.1) years. Patients were followed...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831228/ https://www.ncbi.nlm.nih.gov/pubmed/33532618 http://dx.doi.org/10.1002/edm2.181 |
_version_ | 1783641592563761152 |
---|---|
author | Yokomichi, Hiroshi Nagai, Akiko Hirata, Makoto Mochizuki, Mie Kojima, Reiji Yamagata, Zentaro |
author_facet | Yokomichi, Hiroshi Nagai, Akiko Hirata, Makoto Mochizuki, Mie Kojima, Reiji Yamagata, Zentaro |
author_sort | Yokomichi, Hiroshi |
collection | PubMed |
description | OBJECTIVE: This study aimed to compare cause‐specific mortality rates in patients with type 2 diabetes with and without various vascular complications. METHODS: In Japanese hospitals, we followed up 30 834 patients with a mean age of 64.4 (standard deviation [SD]: 11.1) years. Patients were followed up from 2003 to 2007 for a median of 7.5 (interquartile range: 6.1‐9.7) years. We calculated cause‐specific mortality rates (number of deaths/1000 person‐years) and confounder‐adjusted hazard ratios in patients with macrovascular disease and in those with diabetic nephropathy, neuropathy and retinopathy, allowing for overlap of complications. RESULTS: All‐cause mortality rate was highest (51.4) in the nephropathy group, followed by the macrovascular disease group (45.2), the neuropathy group (39.5), the retinopathy group (38.7) and the nonvascular complication group (18.1). In the nephropathy group, morality rates of ischaemic heart, cerebrovascular, and infectious diseases and cancer were also highest among the groups. However, the cancer mortality rate was similar among the vascular complication groups. Relative to the nonvascular complication group, covariate‐adjusted hazard ratios for ischaemic heart and cerebrovascular disease mortality were triple to quadruple in the macro‐ and microvascular complication groups. All‐cause mortality rates rose exponentially according to age. CONCLUSION: Highest risks of all‐cause, cancer, and ischaemic heart, infectious, and cerebrovascular disease mortality were determined in Japanese patients with diabetic nephropathy. Although cancer is the primary cause of death in Japanese patients with diabetes, cancer mortality rates are similar among those with and without vascular complications. |
format | Online Article Text |
id | pubmed-7831228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78312282021-02-01 Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort Yokomichi, Hiroshi Nagai, Akiko Hirata, Makoto Mochizuki, Mie Kojima, Reiji Yamagata, Zentaro Endocrinol Diabetes Metab Original Research Articles OBJECTIVE: This study aimed to compare cause‐specific mortality rates in patients with type 2 diabetes with and without various vascular complications. METHODS: In Japanese hospitals, we followed up 30 834 patients with a mean age of 64.4 (standard deviation [SD]: 11.1) years. Patients were followed up from 2003 to 2007 for a median of 7.5 (interquartile range: 6.1‐9.7) years. We calculated cause‐specific mortality rates (number of deaths/1000 person‐years) and confounder‐adjusted hazard ratios in patients with macrovascular disease and in those with diabetic nephropathy, neuropathy and retinopathy, allowing for overlap of complications. RESULTS: All‐cause mortality rate was highest (51.4) in the nephropathy group, followed by the macrovascular disease group (45.2), the neuropathy group (39.5), the retinopathy group (38.7) and the nonvascular complication group (18.1). In the nephropathy group, morality rates of ischaemic heart, cerebrovascular, and infectious diseases and cancer were also highest among the groups. However, the cancer mortality rate was similar among the vascular complication groups. Relative to the nonvascular complication group, covariate‐adjusted hazard ratios for ischaemic heart and cerebrovascular disease mortality were triple to quadruple in the macro‐ and microvascular complication groups. All‐cause mortality rates rose exponentially according to age. CONCLUSION: Highest risks of all‐cause, cancer, and ischaemic heart, infectious, and cerebrovascular disease mortality were determined in Japanese patients with diabetic nephropathy. Although cancer is the primary cause of death in Japanese patients with diabetes, cancer mortality rates are similar among those with and without vascular complications. John Wiley and Sons Inc. 2020-08-27 /pmc/articles/PMC7831228/ /pubmed/33532618 http://dx.doi.org/10.1002/edm2.181 Text en © 2020 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Articles Yokomichi, Hiroshi Nagai, Akiko Hirata, Makoto Mochizuki, Mie Kojima, Reiji Yamagata, Zentaro Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort |
title | Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort |
title_full | Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort |
title_fullStr | Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort |
title_full_unstemmed | Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort |
title_short | Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort |
title_sort | cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: biobank japan cohort |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831228/ https://www.ncbi.nlm.nih.gov/pubmed/33532618 http://dx.doi.org/10.1002/edm2.181 |
work_keys_str_mv | AT yokomichihiroshi causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort AT nagaiakiko causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort AT hiratamakoto causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort AT mochizukimie causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort AT kojimareiji causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort AT yamagatazentaro causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort AT causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort |